2025-05-02 10:09:43
Latest Post
Godrej Agrovet Limited consolidated Q4FY25 net profit drops QoQ to Rs. 70.78 crores
L G Balakrishnan & Bros Ltd posts Rs. 84.03 crores consolidated profit in Q4FY25
Swastika Investmart Ltd Q4 FY2025 consolidated profit slumps to Rs. 27.17 lakhs
Vertex Securities Ltd consolidated Q4 FY25 loss at Rs. 53.99 lakhs
The Federal Bank Limited consolidated Q4FY25 PAT jumps to Rs. 1108.31 crores
Stock Report
Bal Pharma Ltd consolidated Q2FY22 net profit at Rs. 1.37 crore
Posted On : 2021-11-13 11:36:27( TIMEZONE : IST )
The Board of Directors of Bal Pharma Limited, at its meeting held today have approved the unaudited Consolidated financial results of the company for the period ended September 30, 2021.
For the quarter ended September 30, 2021(Q2 FY2022), the company's total income was ₹ 67.7312 crore, against ₹64.6242 crore in the corresponding quarter of the previous year (YoY) and ₹70.9632 crore in previous quarter (QoQ).
For the quarter ended September 30, 2021(Q2 FY2022), the company's net profit / (loss) was ₹1.3793 crore, against ₹0.4241 crore in the corresponding quarter of the previous year (YoY) and ₹1.6220 crore in previous quarter (QoQ).
For the quarter ended September 30, 2021(Q2 FY2022), the company's Earnings Per Share (EPS) was ₹0.97, against ₹0.30 in the corresponding quarter of the previous year (YoY) and ₹1.14 in previous quarter (QoQ).
| Financials | Q2 FY2022 | Q1 FY2022 | QoQ % Change | Q2 FY2021 | YoY % Change |
| Total Income | ₹ 67.7312 crs | ₹70.9632 crs |  -4.55% | ₹64.6242 crs |  4.81% |
| Net Profit | ₹1.3793 crs | ₹1.6220 crs | -14.96% | ₹0.4241 crs | 225.23 % |
| EPS | ₹0.97 | ₹1.14 | -14.91% | ₹0.30 | 223.33% |
For the 6 Months period ended September 30, 2021(Half Year Ended FY 2022), the company's total income was ₹138.6944 crore, against ₹116.9098 crore in the previous year (YoY) (Half Year Ended FY 2021).
The net profit / (loss) was at ₹3.0013 crore for the 6 Months period ended September 30, 2021 (Half Year Ended FY 2022), compared to ₹0.8470 crore in the previous year (YoY) (Half Year Ended FY 2021).
The Earnings Per Share stood at ₹2.11 for the 6 Months period ended September 30, 2021 (Half Year Ended FY 2022), against ₹0.60 in the previous year (YoY) (Half Year Ended FY 2021).
| Financials | Half Year Ended FY2022 | Half Year Ended FY2021 | % Change |
| Total Income | ₹138.6944 crs | ₹116.9098 crs | 18.63% |
| Net Profit | ₹3.0013 crs | ₹0.8470 crs | 254.34% |
| EPS | ₹2.11 | ₹0.60 | 251.67% |
Shares of Bal Pharma Limited was last trading in BSE at Rs. 98.75 as compared to the previous close of Rs. 99.90. The total number of shares traded during the day was 3843 in over 202 trades.
The stock hit an intraday high of Rs. 100.10 and intraday low of 97.40. The net turnover during the day was Rs. 378441.00.
